Tisento Therapeutics

Ti sento means I hear you in Italian. At Tisento Therapeutics, we believe that meaningful innovation requires understanding the problem, and that starts with listening. First and foremost, we listen to those impacted by debilitating diseases to understand the daily challenges they face. We also listen to healthcare providers, patient advocates, regulatory agencies, and scientific data. All these inputs inform our thinking and shape how we conduct our research, design our trials, and evolve our company. We are on a mission to deliver medicines that address what matters most. Our lead candidate is zagociguat (formerly CY6463), a Phase 2, first-in-class,...

Rare disease,mitochondrial disease,melas,and drug development

Tisento therapeutics operates in the Biotechnology research industry.

Tisento therapeutics's revenue is 11m - 100m

Tisento therapeutics has 11 - 50 employees.